AnaptysBio, Inc. revenue breakdown overview

AnaptysBio, Inc. revenue for the last year amounted to 91.28 M USD, the most of which — 47.38 M USD — came from its highest performing source at the moment, GSK - Royalty - Jemperli. The greatest contribution to the revenue figure was made by United States and Australia — last year it brought AnaptysBio, Inc. 91.28 M USD, and the year before that — 17.16 M USD.